Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”

“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportuni...

Anacardio går vidare med gynnsamma data och påfylld kassa

Solnabaserade Anacardio har säkrat 205 miljoner kronor i finansiering, och presenterar samtidigt positiva studiedata för sin läkemedelskandidat mot hjärtsvikt.

Eva Arlander rekryteras av Index Pharmaceuticals

Läkemedelsutvecklaren Index Pharmaceuticals har anställt Eva Arlander som Chief Development Officer och medlem i bolagets nya ledningsgrupp. Samtidigt genomförs...

New rules for diagnostic products, but who will certify them? “An extreme shortage area”

In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and...

Forskning kring immunterapier mot cancer belönas med Sjöbergpriset

Årets Sjöbergpris på en miljon dollar går till den amerikanska forskaren Miriam Merad för hennes forskning kring kroppens egen förmåga att bekämpa cancertumörer.

A growing industry in Denmark: “One new life science company a week”

The life science sector in eastern Denmark continues to grow in the number of employees, as well as the number of companies. An emerging problem is the shortage...

A+ Science AB

Marie Gårdmark: New incentives for orphan products on its way

"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...

Fem saker du måste veta om AI 2023

Är ditt jobb hotat av maskininlärning? Varför är det viktigt att hänga med i utvecklingen inom artificiell intelligens? Här får du svar på vad du behöver veta om AI just nu.

Jättestudie: Fördelarna med fetmaläkemedel – och riskerna

Läkemedel som Ozempic kan minska risken för en rad olika sjukdomar och hälsotillstånd, men också öka risken för andra komplikationer. Det enligt en stor amerika...

Study: Our behaviour may have been guided by wishful thinking during the pandemic

A new study suggests that we systematically underestimate health risks if and when it suits us. This was especially true during the pandemic, as our risk assess...

ZEISS Metrology Shop provides planning security

ZEISS Metrology Shop brings it all together.

Tablet treatment for hair loss approved in the USA

The US Drug Administration has given a thumbs up for the first tablet treatment for spotty hair loss.

Sweden is organising a large life science conference as part of the EU presidency

On 26-27 June, Sweden will host a European meeting on life science.

No demand for new Covid vaccine – “It will probably be discarded”

So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...

Tougher competition as the Novo Nordisk Foundation broadens its programme

Søren Nedergaard has worked with innovation at the Danish Government Offices and the University of Copenhagen. Today, he is COO of the Novo Nordisk Foundation, ...

IVI’s Director General on establishing in Sweden: Will need up to 40 employees

The International Vaccine Institute, IVI, hopes to have its first staff on-site in Stockholm within a couple of months, says the institute’s Director General Je...

New diagnostic test soon ready for the market

Novartis köper genterapibolag för 12 miljarder

Den schweiziska läkemedelsjätten Novartis stärker sin portfölj inom genterapier och neuromuskulära sjukdomar genom att förvärva Kate Therapeutics.

Swedish-Danish meeting at Medicon Village: “One of the most important life science congresses”

For the eleventh year, The Future of Swedish and Danish Life Science was held on Wednesday, and the event continues to function as a connecting link between the...

Sobi planerar EMA-ansökan efter positiva studiedata för njurbehandling

Det svenska särläkemedelsbolaget Sobi rapporterar positiva resultat från en fas III-studie med företagets läkemedelskandidat pegcetacoplan mot två sällsynta nju...

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.

Flexibla EOAT-lösningar från OEM Automatic optimerar din robotapplikation

För att maximera potentialen i en robotapplikation krävs rätt verktyg i slutet av robotarmen – så kallade End of Arm Tooling (EOAT). OEM Automatic erbjuder ett ...

Save time and money !

Festo Digital engineering tools helps you to calculate the most cost and efficient solution for your application for free